Bio-Gene Technology Limited appointed Christopher Mark Ramsey as director, effective 12 May 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.061 AUD | +1.67% | +1.67% | +1.67% |
02-25 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
01-19 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.67% | 7.98M | |
+19.57% | 39.94B | |
-.--% | 11.21B | |
+5.80% | 8.33B | |
+2.66% | 6.65B | |
-3.19% | 6.09B | |
-6.17% | 5.6B | |
+39.42% | 5.52B | |
-19.58% | 4.99B | |
-13.45% | 4.8B |
- Stock Market
- Equities
- BGT Stock
- News Bio-Gene Technology Limited
- Bio-Gene Technology Limited Appoints Christopher Mark Ramsey as Director